Clinical Trials on Infertility, Female Infertility, Male Infertility in France

Total 1255 results

Klinikum Nürnberg

Recruiting

A Study to Investigate the Mechanistic Effects of Dapagliflozin Alone or in Combination With Balcinrenone, Compared to Balcinrenone and Placebo on Body Fluid and Electrolyte Handling and Energy Metabolism in Participants Over 50 Years of Age With Chronic Kidney Disease. (DapaBalci-Leap)

Chronic Renal Failure | Mechanistic Effects of SGLT2 Inhibition and/ or MR Antagonism on Body Fluid and Electrolyte Homeostatis

Germany, France
University Hospital, Tours

Recruiting

French National Cohort MATRIX "Renal and Systemic Thrombotic Microangiopathy" (MATRIX)

Kidney Diseases | Hemolytic Uremic Syndrome | Acute Kidney Injury | Thrombotic Microangiopathy | Nephrology

France
Vertex Pharmaceuticals Incorporated

Recruiting

Phase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1- Mediated Proteinuric Kidney Disease (AMPLITUDE)

Proteinuric Kidney Disease

United States, Spain, Ghana, France, United Kingdom, Belgium, Brazil, Colombia, Portugal, Canada, Puerto Rico, Netherlands
Assistance Publique - Hôpitaux de Paris

Recruiting

Clinical and Urodynamic Assessment of Bladder Sensation in Multiple Sclerosis (CUBS-MS)

Overactive Bladder

France
Eastern Cooperative Oncology Group
National Cancer Institute (NCI)

Completed

Chemotherapy in Treating Patients With Early-Stage Bladder Cancer

Bladder Cancer

United States
Pfizer

Terminated

A Study of Avelumab in Real-World Treatment for Patients With Advanced or Metastatic Urothelial Cancer

Bladder Cancer

Brazil, Argentina
Vertex Pharmaceuticals Incorporated

Completed

Phase 2a Study of VX-147 in Adults With APOL1-mediated Focal Segmental Glomerulosclerosis

Glomerulosclerosis, Focal Segmental

United States, France, United Kingdom, Puerto Rico
Dompé Farmaceutici S.p.A

Completed

Reparixin in Prevention of Delayed Graft Function After Kidney Transplantation

Kidney Diseases | Ischemia-Reperfusion Injury

United States, France, Italy, Spain
Poitiers University Hospital
Baxter Healthcare Corporation

Active, not recruiting

Effect of Medium Cut-Off Hemodialysis on Protein Energy Wasting: The EMCOPEW Study (EMCOPEW)

End Stage Renal Disease (ESRD)

France
Institut Cancerologie de l'Ouest

Recruiting

Relapse in Previously Irradiated Prostate Bed : Stereotactic Ablative Reirradiation Potentiated by Metformin (REPAIR)

Prostate Cancer

France
Assistance Publique - Hôpitaux de Paris

Suspended

3-day IV Antibiotic Treatment Versus 3-day IV Followed by 7-day Oral Antibiotic Treatment for AP in Children (PYELOCOURT)

Pyelonephritis Acute

France
Institut Claudius Regaud

Recruiting

Consolidative Radiotherapy for Metastatic Urothelial Bladder Cancer Patients Without Progression and With no More Than Three Residual Metastatic Lesions Following First Line Systemic Therapy (BLAD-RAD01)

Urothelial Bladder Cancer

France
Centre Georges Francois Leclerc

Recruiting

Study Evaluating the Safety and the Efficacy of Combination of Atezolizumab, Tiragolumab and and Stereotactic Body Radiation Therapy in Patients With Oligometastatic Multiorgan (IMMUNOs-SBRT) (IMMUNOs-SBRT)

Metastatic Renal Cell Carcinoma | Metastatic Non Small Cell Lung Cancer | Metastatic Head and Neck Cancer | Metastatic Bladder Cancer

France
Novartis Pharmaceuticals

Completed

Pharmacokinetics and Safety of TIN816 in Patients With Sepsis-associated Acute Kidney Injury

Acute Kidney Injury Due to Sepsis

Hungary, Belgium, Germany, France, Spain
University Hospital, Clermont-Ferrand
Laboratoire HEMOTECH

Withdrawn

Catheter Dysfunction Rate in Patients Undergoing Kidney Replacement Therapy. Evaluation of the Safety and Efficacy of Anti-reflux Valves Without Heparin Lock Solution (DUKE)

Chronic Renal Failure | Haemodialysis, Haemodiafiltration, Haemofiltration | Kidney Replacement Therapy | Catheter Infection, Catheter Dysfunction, Catheter Related Bloodstream Infections

France
Institut Cancerologie de l'Ouest
Astellas Pharma Inc; Direction Générale de l'Offre de Soins

Active, not recruiting

Comparison of Intermittent Androgen Deprivation Therapy With or Without Irradiation Recovery in Prostate Cancer Patients (OLIGOPELVIS2)

Prostate Cancer | Oligometastasis

France
Hospices Civils de Lyon

Not yet recruiting

Study of the Quality of Life in School Aged-children With Posterior Urethral Valves (QUALIVUP)

Quality of Life | Renal Insufficiency | Urinary Incontinence | End Stage Renal Disease | Chronic Renal Disease | Bladder Dysfunction | Posterior Urethral Valve

France
Centre Hospitalier Universitaire de Saint Etienne

Completed

Monocentric Retrospective Cohort Study of the Impact of Advanced Nursing Practice on the Follow-up of the End Stage Chronic Renal Disease Patient (IPASIRC)

Renal Disease

France
Hoffmann-La Roche

Terminated

A Study Evaluating The Safety, Efficacy and Pharmacokinetics Of Ipatasertib In Combination With Atezolizumab And Docetaxel In Metastatic Castration-Resistant Prostate Cancer (mCRPC).

Castration-Resistant Prostatic Cancer

Spain, France, Switzerland, Italy
University Hospital, Bordeaux
Bordeaux PharmacoEpi

Recruiting

Economic Evaluation of Prostatic Urethral Lift (ECOLIFT)

Benign Prostatic Hyperplasia

France
UNICANCER
Janssen Pharmaceutica

Recruiting

Combined Apalutamide, Radiotherapy, and LHRH Agonist in Prostate Cancer Patients After Prostatectomy (CARLHA-2)

Prostate Cancer

France
UNICANCER
Ipsen

Active, not recruiting

Triptorelin and Radiation Therapy in Treating Patients Who Have Undergone Surgery for Intermediate-Risk Stage III or Stage IV Prostate Cancer

Prostate Cancer

France
AB Science

Completed

Masitinib Plus Docetaxel in Metastatic Castration-resistant Prostate Cancer

Metastatic Castrate Resistant Prostate Cancer

Italy, Russian Federation, India, Canada, France, Malaysia
Federal University of Health Science of Porto Alegre

Completed

Acute Effect of Photobiomodulation on Quadriceps Muscle Strength in Patients With Chronic Kidney Failure on Hemodialysis

Renal Insufficiency, Chronic | Renal Dialysis

Brazil
Novartis Pharmaceuticals

Recruiting

A Phase I/II, Open-label, Multi-center Study of [225Ac]Ac-PSMA-R2 in Men With PSMA-positive Prostate Cancer With or Without Prior 177Lu-PSMA Radioligand Therapy.

Metastatic Castration-resistant Prostate Cancer (mCRPC)

France
MedtronicNeuro

Terminated

InterStim Micro Post Market Clinical Follow-up Study (ELITE)

Overactive Bladder | Fecal Incontinence | Non-obstructive Urinary Retention

United States, Netherlands, France, Canada, Switzerland, United Kingdom
ChemoCentryx
Medpace, Inc.

Completed

A Study of CCX140-B in Subjects With FSGS

Focal Segmental Glomerulosclerosis | FSGS | Glomerulosclerosis

United States, France, Italy, Australia, United Kingdom, Canada, New Zealand, Poland
Centre Hospitalier Universitaire de Pointe-a-Pitre
Institut National de la Santé Et de la Recherche Médicale, France

Recruiting

Clinical, Genetic and Environmental Determinants of Prostate Cancer Progression. (KP-CARAIBES)

Adenocarcinoma | Neoplasm Metastasis | Prostatic Neoplasm | Neoplasm Recurrence

France, Guadeloupe
Latin American Cooperative Oncology Group
Astellas Pharma Inc

Terminated

Retrospective Analysis of 68Ga-PSMA-PET in Patients With Prostate Cancer: Experience From Brazil (PET-PSMA)

Prostate Cancer

Brazil
BioCryst Pharmaceuticals

Terminated

BCX9930 for Treatment of PNH in Subjects With Inadequate Response to C5 Inhibitor Therapy (REDEEM-1)

Paroxysmal Nocturnal Hemoglobinuria (PNH)

United Kingdom, Hungary, France, Italy, Spain
Orion Corporation, Orion Pharma

Completed

Safety and Pharmacokinetics of ODM-209 (STESIDES)

Advanced Breast Cancer | Metastatic Breast Cancer | Castration-resistant Prostate Cancer | Prostate Cancer Metastatic

Finland, France, Denmark
Boston Scientific Corporation

Recruiting

Effectiveness of the SpaceOAR Vue System in Subjects With Prostate Cancer Being Treated With Stereotactic Body Radiotherapy (SABRE)

Prostate Cancer

Australia, Spain, United Kingdom, United States, Germany, Ireland, France, Italy, Switzerland
AdministrateurCIC
Pitié-Salpêtrière Hospital; Clinical Investigation Centre for Innovative Technology... and other collaborators

Completed

Motorised Probe Holder Assisting Prostate Biopsies (PROSBOT-Apollo)

Prostate Cancer

France
Assistance Publique - Hôpitaux de Paris

Recruiting

Eculizumab in Hypertensive Emergency-associated Hemolytic Uremic Syndrome (HYPERSHU)

Hypertensive Emergency-associated Hemolytic Uremic Syndrome

France
Novartis Pharmaceuticals

Completed

Study of Safety, Efficacy, Tolerability, Pharmacokinetics and Pharmacodynamics of LNP023 in in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)

Paroxysmal Nocturnal Hemoglobinuria (PNH) With Signs of Active Hemolysis

Italy, Germany, France
Alnylam Pharmaceuticals

Terminated

A Study of Cemdisiran in Adults With Immunoglobulin A Nephropathy (IgAN)

IgA Nephropathy (IgAN) | Berger Disease | Glomerulonephritis, IgA

Canada, Malaysia, France, Sweden, United Kingdom, Philippines, Singapore, Spain, Taiwan
University Hospital, Bordeaux

Recruiting

Cost-utility of Focal HIFU vs Prostatectomy (EMERHIT)

Prostate Cancer

France
Ceevra, Inc.

Completed

Using Virtual Reality (VR) Models for Robotic Prostatectomy

Prostate Cancer

United States
Federal University of Health Science of Porto Alegre

Active, not recruiting

Telehealth in the Rehabilitation of Urinary Incontinence in Older Women

Urinary Incontinence in Old Age

Brazil
Novartis Pharmaceuticals

Completed

Study of Diagnostic Performance of [18F]CTT1057 for PSMA-positive Tumors Detection (GuideView)

Prostatic Neoplasms | Prostate Cancer

Spain, Italy, France, Switzerland, United States
Institut du Cancer de Montpellier - Val d'Aurelle
Ligue contre le cancer, France

Recruiting

Impact of Chronic Renal Failure on Plasma Exposure of Kinase Inhibitors in Patients Treated for Metastatic Kidney Cancer (IREKI)

Kidney Neoplasm

France
Ethicon, Inc.

Recruiting

Post-Market Clinical Follow-Up onTVT EXACT® Continence System

Stress Urinary Incontinence

United States, Germany, Denmark, France, Austria, Sweden
UNICANCER

Recruiting

Prostate-cancer Treatment Using Stereotactic Radiotherapy for Oligometastases Ablation in Hormone-sensitive Patients (Oligo-PRESTO)

Oligometastatic Hormone Sensitive Prostate Cancer

France, Martinique
AstraZeneca

Active, not recruiting

Open-Label, Randomised, Multi-Drug, Biomarker-Directed, Phase 1b Study in Pts w/ Muscle Invasive Bladder Cancer (BISCAY)

Muscle Invasive Bladder Cancer

Spain, United States, Canada, France, United Kingdom
Merck Sharp & Dohme LLC
ModernaTX, Inc.

Recruiting

A Study of Pembrolizumab (MK-3475) Plus V940 in Participants With Bladder Cancer Post-Radical Resection (V940-005)

Bladder Cancer

Canada, New Zealand, Germany, Chile, Australia, United States, Poland, Spain, Sweden, France, Italy
Alnylam Pharmaceuticals

Completed

An Extension Study of an Investigational Drug, Lumasiran (ALN-GO1), in Participants With Primary Hyperoxaluria Type 1

Primary Hyperoxaluria | PH1 | RNAi Therapeutic | siRNA | AGT

France, United Kingdom, Netherlands, Israel, Germany
Bristol-Myers Squibb

Terminated

A Study of Nivolumab or Nivolumab Plus Experimental Medication BMS-986205 With or Without Bacillus Calumette-Guerin (BCG) in BCG Unresponsive Bladder Cancer That Has Not Invaded Into the Muscle Wall of the Bladder (CheckMate 9UT)

Urinary Bladder Neoplasms

United States, Argentina, Australia, Brazil, Canada, Chile, China, France, Mexico, Netherlands, Spain, United Kingdom, Italy, Hong Kong, Russian Federation
Janssen Research & Development, LLC

Active, not recruiting

A Study of Comparative Formulations of Niraparib and Abiraterone Acetate (AA) in Men With Prostate Cancer

Prostatic Neoplasms

Belgium, Netherlands, Sweden, Poland, United States, France, Spain, Georgia, Moldova, Republic of, United Kingdom, Ukraine
Novartis Pharmaceuticals

Recruiting

Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN (APPARENT)

IC-MPGN

France, Germany, Spain, Switzerland, Japan, United States, Canada, India, United Kingdom, Israel, Brazil, Turkey, Italy, Vietnam, Argentina, Czechia, Poland
AlloVir

Terminated

Study to Evaluate Viralym-M (ALVR105) for the Treatment of Virus-Associated Hemorrhagic Cystitis (HC)

BK Virus Infection | Hemorrhagic Cystitis

Korea, Republic of, United States, Italy, Sweden, United Kingdom, Spain, France

Clinical Trials on Infertility, Female Infertility, Male Infertility in France

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Belarus

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations